Eli Lilly (LLY) Cash from Investing Activities (2009 - 2026)
Eli Lilly posted quarterly Cash from Investing Activities of -$3.9 billion for Q1 2026, down 16.79% year-on-year from -$4.7 billion in Q1 2025, and down 39.75% on a QoQ basis from -$2.8 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Cash from Investing Activities data on file, last reported at -$3.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 16.79% year-over-year to -$3.9 billion; the trailing twelve-month figure through Mar 2026 stood at -$11.5 billion (down 0.5% YoY), and the FY2025 full-year result was -$11.0 billion, down 17.95% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$3.9 billion, down from -$2.8 billion in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$459.1 million in Q2 2023 and bottomed at -$4.0 billion in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$1.9 billion (2024), against an average of -$2.1 billion.
- The widest annual swing landed in 2023, when Cash from Investing Activities jumped 44.45%; it then tumbled 378.92% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$943.5 million in 2022, then sank by 209.97% to -$2.9 billion in 2023, then soared by 34.32% to -$1.9 billion in 2024, then sank by 45.87% to -$2.8 billion in 2025, then plunged by 39.75% to -$3.9 billion in 2026.
- The last three Cash from Investing Activities figures came in at -$3.9 billion (Q1 2026), -$2.8 billion (Q4 2025), and -$3.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -3.92 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -1.04 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -574.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -10.21 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -716.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.77 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 785.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -131.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.92 Bn |
| Mar 31, 2026 | -3.92 Bn |
| Dec 31, 2025 | -2.80 Bn |
| Dec 31, 2025 | -2.80 Bn |
| Sep 30, 2025 | -2.98 Bn |
| Sep 30, 2025 | -2.98 Bn |
| Jun 30, 2025 | -1.83 Bn |
| Jun 30, 2025 | -1.83 Bn |
| Mar 31, 2025 | -3.35 Bn |
| Mar 31, 2025 | -3.35 Bn |
| Dec 31, 2024 | -1.92 Bn |
| Dec 31, 2024 | -1.92 Bn |
| Sep 30, 2024 | -4.00 Bn |
| Sep 30, 2024 | -4.00 Bn |
| Jun 30, 2024 | -2.20 Bn |
| Jun 30, 2024 | -2.20 Bn |
| Mar 31, 2024 | -1.18 Bn |
| Mar 31, 2024 | -1.18 Bn |
| Dec 31, 2023 | -2.92 Bn |
| Dec 31, 2023 | -2.92 Bn |
| Sep 30, 2023 | -3.08 Bn |
| Sep 30, 2023 | -3.08 Bn |
| Jun 30, 2023 | -459.10 Mn |
| Jun 30, 2023 | -459.10 Mn |
| Mar 31, 2023 | -688.80 Mn |
| Mar 31, 2023 | -688.80 Mn |
| Dec 31, 2022 | -943.50 Mn |
| Dec 31, 2022 | -943.50 Mn |
| Sep 30, 2022 | -955.30 Mn |
| Sep 30, 2022 | -955.30 Mn |
| Jun 30, 2022 | -826.50 Mn |
| Jun 30, 2022 | -826.50 Mn |
| Mar 31, 2022 | -1.04 Bn |
| Mar 31, 2022 | -1.04 Bn |
| Dec 31, 2021 | -484.20 Mn |
| Dec 31, 2021 | -484.20 Mn |
| Sep 30, 2021 | -616.50 Mn |
| Sep 30, 2021 | -616.50 Mn |
| Jun 30, 2021 | -483.30 Mn |
| Jun 30, 2021 | -483.30 Mn |
| Mar 31, 2021 | -1.28 Bn |
| Mar 31, 2021 | -1.28 Bn |
| Dec 31, 2020 | -674.10 Mn |
| Dec 31, 2020 | -674.10 Mn |
| Sep 30, 2020 | -313.50 Mn |
| Sep 30, 2020 | -313.50 Mn |
| Jun 30, 2020 | -210.40 Mn |
| Jun 30, 2020 | -210.40 Mn |
| Mar 31, 2020 | -1.06 Bn |
| Mar 31, 2020 | -1.06 Bn |
| Dec 31, 2019 | -41.40 Mn |
| Dec 31, 2019 | -41.40 Mn |
| Sep 30, 2019 | -423.80 Mn |
| Sep 30, 2019 | -423.80 Mn |
| Jun 30, 2019 | 61.00 Mn |
| Jun 30, 2019 | 61.00 Mn |
| Mar 31, 2019 | -7.68 Bn |
| Mar 31, 2019 | -7.68 Bn |
| Dec 31, 2018 | -659.00 Mn |
| Dec 31, 2018 | -659.00 Mn |
| Sep 30, 2018 | -398.10 Mn |
| Sep 30, 2018 | -398.10 Mn |
| Jun 30, 2018 | 3.13 Bn |
| Jun 30, 2018 | 3.13 Bn |
| Mar 31, 2018 | -170.30 Mn |
| Mar 31, 2018 | -170.30 Mn |
| Dec 31, 2017 | 1.65 Bn |
| Dec 31, 2017 | 1.65 Bn |
| Sep 30, 2017 | -1.76 Bn |
| Sep 30, 2017 | -1.76 Bn |
| Jun 30, 2017 | -2.25 Bn |
| Jun 30, 2017 | -2.25 Bn |
| Mar 31, 2017 | -1.43 Bn |
| Mar 31, 2017 | -1.43 Bn |
| Dec 31, 2016 | -1.18 Bn |
| Dec 31, 2016 | -1.18 Bn |
| Sep 30, 2016 | -794.70 Mn |
| Sep 30, 2016 | -794.70 Mn |
| Jun 30, 2016 | -1.02 Bn |
| Jun 30, 2016 | -1.02 Bn |
| Mar 31, 2016 | -145.40 Mn |
| Mar 31, 2016 | -145.40 Mn |
| Dec 31, 2015 | 253.70 Mn |
| Dec 31, 2015 | 253.70 Mn |
| Sep 30, 2015 | -570.10 Mn |
| Sep 30, 2015 | -570.10 Mn |
| Jun 30, 2015 | 182.40 Mn |
| Jun 30, 2015 | 182.40 Mn |
| Mar 31, 2015 | 160.80 Mn |
| Mar 31, 2015 | 160.80 Mn |
| Dec 31, 2014 | -2.18 Bn |
| Dec 31, 2014 | -2.18 Bn |
| Sep 30, 2014 | -1.65 Bn |
| Sep 30, 2014 | -1.65 Bn |
| Jun 30, 2014 | -468.90 Mn |
| Jun 30, 2014 | -468.90 Mn |
| Mar 31, 2014 | 388.40 Mn |
| Mar 31, 2014 | 388.40 Mn |
| Dec 31, 2013 | -1.23 Bn |
| Dec 31, 2013 | -1.23 Bn |
| Sep 30, 2013 | -943.80 Mn |
| Sep 30, 2013 | -943.80 Mn |
| Jun 30, 2013 | -1.25 Bn |
| Jun 30, 2013 | -1.25 Bn |
| Mar 31, 2013 | 1.36 Bn |
| Mar 31, 2013 | 1.36 Bn |
| Dec 31, 2012 | -1.66 Bn |
| Dec 31, 2012 | -1.66 Bn |
| Sep 30, 2012 | -132.70 Mn |
| Sep 30, 2012 | -132.70 Mn |
| Jun 30, 2012 | -385.30 Mn |
| Jun 30, 2012 | -385.30 Mn |
| Mar 31, 2012 | -652.30 Mn |
| Mar 31, 2012 | -652.30 Mn |
| Dec 31, 2011 | -1.88 Bn |
| Dec 31, 2011 | -1.88 Bn |
| Sep 30, 2011 | -1.01 Bn |
| Sep 30, 2011 | -1.01 Bn |
| Jun 30, 2011 | -1.90 Bn |
| Jun 30, 2011 | -1.90 Bn |
| Mar 31, 2011 | -40.70 Mn |
| Mar 31, 2011 | -40.70 Mn |
| Dec 31, 2010 | -1.56 Bn |
| Dec 31, 2010 | -1.56 Bn |
| Sep 30, 2010 | -788.50 Mn |
| Sep 30, 2010 | -788.50 Mn |
| Jun 30, 2010 | -754.20 Mn |
| Jun 30, 2010 | -754.20 Mn |
| Mar 31, 2010 | -52.60 Mn |
| Mar 31, 2010 | -52.60 Mn |
| Dec 31, 2009 | -254.30 Mn |
| Dec 31, 2009 | -254.30 Mn |
| Sep 30, 2009 | 67.70 Mn |
| Sep 30, 2009 | 67.70 Mn |
| Jun 30, 2009 | 102.10 Mn |
| Jun 30, 2009 | 102.10 Mn |
| Mar 31, 2009 | 227.30 Mn |
| Mar 31, 2009 | 227.30 Mn |